Welcome to our dedicated page for BlackRock Resources & Commdty news (Ticker: BCX), a resource for investors and traders seeking the latest updates and insights on BlackRock Resources & Commdty stock.
BlackRock Resources & Commdty (NYSE: BCX), a closed-end trust targeting commodity and natural resource investments, provides this centralized hub for all corporate news and market developments. Investors and analysts will find timely updates on earnings reports, strategic initiatives, and sector-specific trends impacting the trust's performance.
This resource aggregates BCX's official press releases, regulatory filings, and third-party analyses to deliver a comprehensive view of its activities in global commodity markets. Key updates include dividend announcements, portfolio adjustments, and insights into derivative strategies tied to energy, metals, and agricultural resources.
Designed for efficient research, the page enables users to monitor BCX's execution of its dual income-and-growth mandate while staying informed about broader commodity market dynamics. Content is curated to highlight material events without speculative commentary, maintaining compliance with financial disclosure standards.
Bookmark this page or check regularly to access BCX's latest developments, including partnership announcements, liquidity updates, and analyses of its equity/derivative balance. All content is sourced from verified channels to ensure accuracy in this volatile investment sector.
BlackRock has announced the final results of tender offers for two of its closed-end funds: BlackRock Enhanced Global Dividend Trust (BOE) and BlackRock Resources & Commodities Strategy Trust (BCX). Each fund offered to purchase up to 2.5% of its outstanding common shares. The tender offers, which expired on May 19, 2025, were oversubscribed for both funds.
For BOE, 12,288,978 shares were tendered, with 1,425,644 shares to be purchased at $11.8776 per share (98% of NAV) with a pro-ration factor of 0.11614930. For BCX, 14,138,859 shares were tendered, with 1,954,822 shares to be purchased at $9.7314 per share with a pro-ration factor of 0.13831200. Payments are expected within five business days after the expiration date.
BlackRock announced final results for tender offers of three closed-end funds. The offers, which expired on November 19, 2024, were oversubscribed for each fund. Each fund will purchase shares from tendering shareholders on a pro rata basis. For BlackRock Science and Technology Term Trust (BSTZ), 19,714,994 shares were tendered, with 1,854,222 to be purchased at $22.3440 per share, representing a pro-ration factor of 0.09414755. Similar results were reported for BCX and BOE funds. Payments are expected within five business days after expiration.
BlackRock announced the expiration and preliminary results of tender offers for three closed-end funds: BSTZ, BCX, and BOE. Each fund offered to repurchase up to 2.5% of its outstanding common shares. The tender offers were significantly oversubscribed, with BCX receiving 20,587,371 shares tendered against 2,056,355 shares offered for repurchase. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of November 20, 2024.
BlackRock closed-end funds announced final results of their tender offers for up to 2.5% of outstanding common shares. The offers, which expired on August 20, 2024, were oversubscribed for each fund. As a result, shares will be purchased from all tendering shareholders on a pro rata basis. The BlackRock Science and Technology Term Trust (BSTZ) had 23,251,771 shares tendered, with 1,901,766 to be purchased at $21.4522 per share. The pro-ration factor for BSTZ is 0.08188543. Two other BlackRock funds, BCX and BOE, also reported their tender offer results. Payments for accepted shares are expected within five business days after the expiration date.
BlackRock closed-end funds BSTZ, BCX, and BOE announced the expiration and preliminary results of their tender offers for up to 2.5% of outstanding common shares. The offers, which began on July 19, 2024, and ended on August 20, 2024, were significantly oversubscribed. BSTZ offered 1,901,766 shares but received tenders for 23,251,771 shares. BCX and BOE also saw high demand, with tenders exceeding the offered amounts by over 10 times. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of August 21, 2024. Final results, including pro-ration factors, are expected to be announced around August 21, 2024.